This site makes use of Javascript, please enable your web browser to allow Javascript. Thank you.
Alumni | RSS | AA | Languages
 

RSS Feeds

RSS Feed - Life Sciences - Kaye Scholer LLP

Current Feed: http://www.kayescholer.com/practice/rss.xml?p=life_sciences

> Change Feed

Supreme Court Requires Full Rule of Reason Analysis in So-Called “Reverse Payment” Settlements of Patent Litigation (06/19/13)

Supreme Court Requires Full Rule of Reason Analysis in So-Called “Reverse Payment” Settlements of Patent Litigation (06/19/13)

Thomas A. Smart (06/18/13)

Thomas A. Smart has litigated a wide variety of false advertising, consumer fraud, trademark, trade dress, counterfeiting, cybersquatting and copyright cases while in Kaye Scholer’s Trademark, Copyright and False Advertising group.

20 Kaye Scholer Lawyers Recognized in Who’s Who Legal 100 (06/18/13)

Gerald Sobel (06/12/13)

Landmark Litigation

Gerald Sobel has litigated and tried many complex cases in over 40 years of practice. His trials include landmark wins in cases of exceptional complexity and novel legal issues. By way of example, he represented Xerox in its win in the SCM v. Xerox case, including a year-long antitrust trial involving office copier technology in the District of Connecticut – the longest federal civil jury trial; was lead counsel for Xoma in its win on patent infringement against Centocor before a San Francisco jury – the longest biotech patent trial; and was lead counsel for Pfizer against the University of Rochester, in its win in the Celebrex® patent infringement case on summary judgment and then on appeal at the Federal Circuit.

Partner Stephen Holmes Discusses Newly Announced Initiatives to Curb ‘Patent Trolls’ (06/11/13)

Intellectual Property Department Praised in IAM Patent 1000 2013 (06/10/13)

William Hoffman (06/10/13)

William Hoffman is an experienced trial and appellate lawyer who has represented a wide range of clients in major product liability and other complex litigation, criminal investigations, actions by State Attorneys General, regulatory matters and litigation avoidance counseling. William has tried a number of cases to verdict in both state and federal court, has argued numerous appeals and conducted evidentiary hearings. He is a member of the DC Circuit’s Appointed Counsel Panel.

Lori B. Leskin (06/10/13)

Lori B. Leskin, Partner and Co-Chair of the Product Liability group, is valued by her clients for her ability to successfully assess, strategize and implement unique solutions to their unique problems. Lori’s leadership is evidenced by her appointment as Co-Chair of the Products Liability Committee of the American Bar Association’s Section of Litigation and her inclusion in The Legal 500 US 2013 for Litigation - Product liability and mass tort defense: pharmaceuticals and medical devices. Lori is also recognized by US News & World Report Best Lawyers 2013, which ranks Kaye Scholer as a National Tier 1 firm for Mass Tort Litigation/Class Actions – Defendants. Additionally, she was shortlisted for the 2013 Euromoney LMG Americas Women in Business Law Awards for the “Best in Litigation” category. She was also recognized as a leader in New York Mass Tort Litigation/Class Actions by The Best Lawyers in America 2013. In 2012 she was named “Life Science Star” in the inaugural issue of Euromoney’s LMG Life Sciences Guide and placed among the The International Who’s Who of Life Sciences Lawyers 2010-2012, which recognized Kaye Scholer as “one of the most well regarded firms” for Life Sciences. Her Products Liability practice group was named Product Liability Firm of the Year at the 2008 Chambers and Partners “USA Awards for Excellence” ceremony and “Best Product Liability Practice” in January 2006 by The American Lawyer. In 2012 her group was also ranked as a top tier practice by Chambers USA, and was referenced as “[A]bsolute experts and incredible strategic thinkers. They have the ability to understand their client and what we are most concerned about, and getting to the objective in the most cost-effective and efficient manner while ensuring you get the results you want.”

Kaye Scholer Represents Pfizer in Acquisition of NextWave Pharmaceuticals (06/07/13)

Subscribe

 
 
Practice Practice Groups Industry Groups Regional Groups Pro Bono Professionals Firm Careers Diversity Pro Bono Newsroom Events Offices